Pharmacokinetics of methylprednisolone, methylprednisolone sodium succinate, and methylprednisolone acetate in dogs.

The absolute bioavailability and pharmacokinetic parameters of two methylprednisolone formulations (methylprednisolone sodium succinate and methylprednisolone acetate) were determined in five dogs. Plasma concentrations of methylprednisolone, methylprednisolone sodium succinate, and methylprednisolone acetate were measured by sensitive and specific high-performance liquid chromatographic methods. After intravenous methylprednisolone sodium succinate administration, methylprednisolone was released rapidly but the extent of availability was rather low (43.6%). This has been tentatively explained in terms of its subsequent single-pass metabolism in the liver, i.e., hepatic hydrolysis of methylprednisolone sodium succinate followed by immediate hepatic elimination of the released methylprednisolone. After intramuscular administration of methylprednisolone acetate, its absorption was slow (half-time of absorption, 69.04 h) and the availability of the released methylprednisolone was low (42.7%). Therapeutic implications of these results are discussed, especially those which are relevant to shock therapy.

[1]  H. Möllmann,et al.  Kinetics of methylprednisolone and its hemisuccinate ester , 1985, Clinical pharmacology and therapeutics.

[2]  W. Jusko,et al.  Methylprednisolone disposition in rabbits. Analysis, prodrug conversion, reversible metabolism, and comparison with man. , 1985, Drug metabolism and disposition: the biological fate of chemicals.

[3]  B. D. Anderson,et al.  Strategies in the design of solution-stable, water-soluble prodrugs III: influence of the pro-moiety on the bioconversion of 21-esters of corticosteroids. , 1985, Journal of pharmaceutical sciences.

[4]  W. Jusko,et al.  Tissue distribution of prednisolone in the rabbit. , 1984, The Journal of pharmacology and experimental therapeutics.

[5]  M. Alvinerie,et al.  Determination of methylprednisolone and methylprednisolone acetate in synovial fluid using high-performance liquid chromatography. , 1984, Journal of chromatography.

[6]  E. Nüesch.  Noncompartmental approach in pharmacokinetics using moments. , 1984, Drug metabolism reviews.

[7]  W. Jusko,et al.  Analysis of cortisol, methylprednisolone, and methylprednisolone hemisuccinate. Absence of effects of troleandomycin on ester hydrolysis. , 1984, Journal of chromatography.

[8]  J. Gallelli,et al.  Systemic bioavailability and pharmacokinetics of methylprednisolone in patients with rheumatoid arthritis following ‘high‐dose’ pulse administration , 1983, Biopharmaceutics & drug disposition.

[9]  Blaisdell Fw.  Controversy in shock research. Con: The role of steroids in septic shock. , 1981 .

[10]  T. Clekis,et al.  Adrenal gland function in dogs given methylprednisolone. , 1980, American journal of veterinary research.

[11]  K. Hattori,et al.  Hydrolysis of methylprednisolone hemisuccinate to methylprednisolone by a nonspecific carboxylesterase. , 1980, Pharmacological research communications.

[12]  M. D. Smith.  High-performance liquid chromatographic determination of hydrocortisone and methylprednisolone and their hemisuccinate esters in human serum. , 1979, Journal of chromatography.

[13]  C. J. Wright,et al.  Steroids and severe hemorrhagic shock. , 1977, Surgery.

[14]  Jordan Je.  Normal laboratory values in Beagle dogs of twelve to eighteen months of age. , 1977 .

[15]  A. Comeau,et al.  Genetic polymorphism of plasma carboxylesterases in the rabbit: correlation with pharmacologic and toxicologic effects. , 1974, Toxicology and applied pharmacology.

[16]  Philip L. Altman,et al.  Respiration and Circulation , 1971 .

[17]  S. Chien.  Role of the sympathetic nervous system in hemorrhage. , 1967, Physiological reviews.

[18]  S. Cros,et al.  LIMITS OF TOXIC AND TERATOGENIC TOLERANCE OF DIMETHYL SULFOXIDE , 1967, Annals of the New York Academy of Sciences.

[19]  C. Schlagel,et al.  ABSORPTION, METABOLISM AND EXCRETION OF 6-ALPHA-METHYL-PREDNISOLONE-3H,21-ACETATE FOLLOWING ORAL AND INTRAMUSCULAR ADMINISTRATIONS IN THE DOG. , 1965, Endocrinology.

[20]  J. Melby,et al.  Comparative studies on absorption and metabolic disposal of water-soluble corticosteroid esters. , 1961, Metabolism: clinical and experimental.

[21]  W. Jakoby,et al.  Enzymatic detoxification mechanism for viadril. , 1956, Science.